Specialty pharmaceuticals
Drug safety issues;

Monitor drug pricing legislation;

Continued monitoring drug pricing legislation, including S. 1435, Affordable Prescriptions for Patients Act; H.R. 2873, Affordable Prescriptions for Patients Through Promoting Competition Act; H.R. 3, Elijah E. Cummings Lower Drug Costs Now; Prescription Drug Pricing Reduction Act;

Senate Finance Committee Prescription Drug Pricing Reform Principles;

Implementation of American Rescue Plan Act of2021 (PL 117-2);

H.R. 5376, Build Back Better Act; 

Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, adding Medicare enhancements/supplemental benefits (hearing, dental, vision), addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform; 

Proposed repeal of the CMS Rule on Most Favored Nation Model; 

Delay of the Rebate Rule; 

PL 117-58 - Infrastructure Investment and Jobs Act (BIF) - issues related to rebate rule delay, repurposed Provider Relief Funds, Medicare savings from single source vial size drug policy and extension of mandatory sequester); 

PL-117-71 Protecting Medicare and American Families from Sequester Cuts Act - specifically:  6 months relief from 2% Medicare sequester, 4% statutory Pay-As-You-Go Act, 1 year relief of physician conversion factor cuts, 1 year delay of clinical lab (PAMA) cuts, delay of radiation oncology demo S. 1435, Affordable Prescriptions for Patients Act of 2021
HCR - Health Issues CPT - Copyright/Patent/Trademark
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
TRACY SPICER TRACY SPICER